Physician
Venkat, Suryadutt
Venkat, Suryadutt was paid $514K by Medicaid between Jul 2018 and Sep 2023, across 34 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoVENKAT, SURYADUTT
FRISCO, TX 75034
FRISCO, TX 75034
33aNPI1376700039assigned 05/20/2008
33bProvider typeGeriatric Medicine (Family Medicine) Physician
28Total paid$514K
24GClaims12,955
24DCodes billed34
24AFirst – last monthJul 2018 – Sep 2023
Compared with peers
Next to other Geriatric Medicine (Family Medicine) Physician providers in Texas
Rank by total paid#2 of 35
Median peer was paid$14K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,062 | $36K | |
| 2019 | 864 | $22K | |
| 2020 | 3,430 | $157K | |
| 2021 | 4,859 | $181K | |
| 2022 | 2,439 | $102K | |
| 2023 | 301 | $17K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 2,740 | 2,348 | $143K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.6% | 650 | 589 | $49K |
| 92587 | 8.5% | 915 | 876 | $44K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.2% | 509 | 497 | $37K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.7% | 1,417 | 1,369 | $34K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.5% | 1,170 | 1,088 | $23K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.4% | 290 | 274 | $23K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.4% | 35 | 35 | $23K |
| 82465 | 3.5% | 805 | 790 | $18K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.3% | 260 | 249 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.1% | 156 | 141 | $16K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.0% | 91 | 91 | $15K |
22 more codes
| 82947 | 2.8% | 781 | $14K | |
| 90461 | 1.7% | 242 | $9K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 594 | $7K |
| 87486 | 1.1% | 53 | $6K | |
| 87581 | 1.1% | 53 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 39 | $6K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 70 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 74 | $4K |
| 96127 | <1% | 1,140 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 42 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 24 | $2K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 26 | $2K |
| 85027 | <1% | 53 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 20 | $1K |
| 92552 | <1% | 88 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 32 | $1K |
| 87428 | <1% | 14 | $731.46 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 50 | $442.22 |
| 99173 | <1% | 134 | $288.05 | |
| 90686 | <1% | 288 | $2.88 | |
| 3078F | <1% | 73 | $0.28 | |
| 1036F | <1% | 27 | $0.13 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.